Appendix 4E Preliminary Final Report 1. Memphasys Limited (ASX: MEM ) • Reporting Period: Year ended 3 0 June 2026 • Previous Corresponding Period: Year ended 3 0 June 2025 2. Preliminary Results for Announcement to the Market 2.1 All amounts are presented in thousands of...
Appendix 4E and 2026 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Memphasys
- Felix Early Thai FDA Approval, Commercial Launch Accelerates
- Results of General Meeting
- Felix Registration Achieved in Vietnam and Cartridge Order
- Pivotal Felix Study Receives First Scientific Presentation
- European Commercial Roll-out continues with Poland Agreement
Later from Memphasys
- Appendix 4G and Corporate Governance Statement
- EUR526,500 Nordic Agreement Expands Felix European Footprint
- Notification of cessation of securities - MEM
- Felix Registration Achieved in Turkey, Sales Commence
- Investor Webinar Invite
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys